Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹269Cr
Rev Gr TTM
Revenue Growth TTM
1.22%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

NOVAAGRI
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | -16.4 | 40.8 | -3.3 | 20.0 | 21.1 | 12.4 | 14.9 | 11.6 | 11.7 | -24.5 |
| 58 | 28 | 56 | 63 | 61 | 36 | 71 | 73 | 72 | 41 | 80 | 60 |
Operating Profit Operating ProfitCr |
| 21.1 | 20.3 | 17.9 | 19.2 | 14.0 | 14.1 | 14.3 | 17.4 | 11.8 | 11.5 | 13.0 | 9.7 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 3 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 |
| 12 | 4 | 10 | 12 | 7 | 5 | 10 | 14 | 9 | 4 | 9 | 3 |
| 4 | 1 | 3 | 3 | -1 | 1 | 4 | 3 | 3 | 1 | 3 | 1 |
|
Growth YoY PAT Growth YoY% | | | 1.2 | 73.4 | 2.6 | 24.4 | -2.5 | 9.5 | -29.8 | -24.1 | -0.1 | -75.3 |
| 11.0 | 9.8 | 10.2 | 12.3 | 11.7 | 10.2 | 8.2 | 12.0 | 7.1 | 7.0 | 7.3 | 3.9 |
| 1.3 | 0.6 | 1.1 | 1.5 | 1.2 | 0.5 | 0.8 | 1.2 | 0.7 | 0.4 | 0.7 | 0.3 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -3.1 | 26.8 | 15.5 | 13.4 | 19.9 | 16.5 | -2.4 |
| 118 | 113 | 143 | 158 | 172 | 208 | 251 | 254 |
Operating Profit Operating ProfitCr |
| 10.1 | 10.7 | 11.1 | 15.0 | 18.5 | 17.6 | 14.5 | 11.6 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 |
Interest Expense Interest ExpenseCr | 3 | 6 | 7 | 7 | 9 | 9 | 5 | 5 |
Depreciation DepreciationCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 |
| 7 | 5 | 9 | 18 | 28 | 33 | 38 | 26 |
| 3 | 2 | 2 | 5 | 8 | 5 | 11 | 7 |
|
| | -39.0 | 111.4 | 117.3 | 49.7 | 38.2 | -3.1 | -32.8 |
| 3.7 | 2.4 | 3.9 | 7.4 | 9.7 | 11.2 | 9.3 | 6.4 |
| 3.9 | 2.4 | 5.0 | 2.2 | 3.3 | 4.2 | 3.0 | 2.0 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 13 | 13 | 13 | 13 | 13 | 19 | 19 | 19 |
| 14 | 10 | 17 | 31 | 51 | 175 | 201 | 211 |
Current Liabilities Current LiabilitiesCr | 82 | 89 | 95 | 92 | 99 | 96 | 111 | 134 |
Non Current Liabilities Non Current LiabilitiesCr | 10 | 19 | 23 | 25 | 18 | 9 | 5 | 4 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 99 | 111 | 126 | 137 | 158 | 272 | 294 | 304 |
Non Current Assets Non Current AssetsCr | 20 | 20 | 22 | 23 | 22 | 26 | 42 | 64 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 3 | -9 | 5 | 2 | 6 | 1 | -18 |
Investing Cash Flow Investing Cash FlowCr | -3 | -1 | -3 | -4 | -2 | -23 | -26 |
Financing Cash Flow Financing Cash FlowCr | -1 | 10 | -2 | 3 | -2 | 82 | -12 |
|
Free Cash Flow Free Cash FlowCr | 0 | -10 | 2 | -2 | 3 | 0 | -44 |
| 69.3 | -300.1 | 82.2 | 18.1 | 27.7 | 2.8 | -67.2 |
CFO To EBITDA CFO To EBITDA% | 25.7 | -66.0 | 29.0 | 8.9 | 14.6 | 1.8 | -43.2 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 0 | 0 | 468 | 395 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 16.5 | 14.4 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.9 | 1.3 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.4 | 1.8 |
| 2.3 | 3.4 | 2.8 | 2.3 | 1.7 | 10.0 | 9.8 |
Profitability Ratios Profitability Ratios |
| 47.9 | 44.0 | 38.3 | 38.9 | 42.4 | 37.9 | 31.1 |
| 10.1 | 10.7 | 11.1 | 15.0 | 18.5 | 17.6 | 14.5 |
| 3.7 | 2.4 | 3.9 | 7.4 | 9.7 | 11.2 | 9.3 |
| 19.2 | 16.3 | 19.9 | 23.8 | 27.4 | 16.6 | 15.8 |
| 18.2 | 13.0 | 21.4 | 31.7 | 32.1 | 14.6 | 12.5 |
| 4.1 | 2.3 | 4.3 | 8.5 | 11.3 | 9.5 | 8.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Nova Agritech Limited (**NATL**) is an integrated, technology-driven agri-input manufacturer specializing in ecologically sustainable solutions for soil health, crop nutrition, and crop protection. Following its listing on the **BSE** and **NSE** on **January 31, 2024**, the company has transitioned from a project-execution phase to a full-scale operational phase, leveraging a farmer-driven business model that integrates in-house **R&D**, advanced manufacturing, and a grassroots distribution network.
---
### **Integrated Product Ecosystem & Technological Innovation**
NATL provides a "one-stop solution" for agriculture through seven distinct product categories. As of **March 31, 2024**, the company and its subsidiaries held a total of **723 product registrations**.
#### **Core Product Verticals**
* **Soil Health Management:** Organic fertilizers, bio-fertilizers, and soil conditioners (**7 registrations**).
* **Crop Nutrition:** 100% water-soluble **NPK** mixtures, micronutrients, and beneficial element fertilizers like **HY-Clean** (**173 registrations**).
* **Crop Protection:** Insecticides, fungicides, and herbicides manufactured primarily through the wholly-owned subsidiary **Nova Agri Sciences Private Limited (NASPL)** (**528 registrations**).
* **Bio-Stimulants & Bio-Pesticides:** Ecologically balanced growth management. While the bio-pesticide range was slated for a late 2024 introduction, the company received government approval for **43 biostimulant products** in **January 2026**, valid through **September 2029**.
* **Integrated Pest Management (IPM):** Specialized tools including chromatic traps, pheromone lures, and sticky sheets.
#### **Precision Farming & New Technologies**
NATL is diversifying into high-margin hardware and IoT solutions to modernize Indian agriculture:
* **Nova Agribot:** A **DGCA-approved** agricultural drone developed via an MOU with **IoTechWorld Avigation**. It can spray **1 acre in 5-10 minutes** (covering **30-35 acres per day**) and utilizes multi-spectral sensors for crop health monitoring.
* **Bhu Parikshak:** An **IoT-enabled**, portable soil-testing device using **Near Infrared Spectroscopy (NIR)**. It provides soil health analysis and fertilizer recommendations via a mobile app in **90 seconds**, capable of testing **120 samples** per charge.
---
### **Manufacturing Infrastructure & R&D Capabilities**
The company has significantly scaled its production capacity using proceeds from its **₹112 crore** IPO fresh issue.
#### **Production Capacity (Commissioned July 7, 2025)**
| Entity | Location | Capacity (MTPA) | Utilization (Approx.) |
| :--- | :--- | :--- | :--- |
| **Nova Agritech Limited (NATL)** | Siddipet, Telangana | **14,592** | **48%** |
| **Nova Agri Sciences Pvt Ltd (NASPL)** | Siddipet, Telangana | **13,269.6** | **48%** |
#### **Research & Development**
* **Recognition:** In-house R&D facility recognized by the **DSIR** (valid through Sept 2024), allowing for customs duty exemptions.
* **Investment:** NATL reinvests approximately **2% of revenue** into R&D.
* **Field Trials:** Maintains a **67.13-acre** leased site in Andhra Pradesh for efficacy trials and a research incubation center.
* **Academic Partnerships:** Strategic agreement with **Koneru Lakshmaiah Education Foundation (KLEF)** for R&D and skill development.
---
### **Distribution Strategy & Market Footprint**
NATL utilizes a multi-tier distribution strategy to penetrate remote rural markets, supported by a dedicated outreach arm.
* **Dealer Network:** Approximately **11,823 total dealers** across **16–18 states**, with **6,000+ active dealers** in recent cycles.
* **Nova Kisan Seva Kendra (NKSK):** A grassroots technical team comprising **16 agri-graduate coordinators**, **86 Kisan Mitras**, and **80 Kisan Sevaks** providing live demonstrations and technical guidance.
* **Geographical Concentration:** While expanding nationally, revenue remains concentrated in Southern India.
| Market | Revenue Contribution (FY25) |
| :--- | :--- |
| **Telangana** | **~55%** |
| **Andhra Pradesh** | **23%** |
| **Karnataka** | **6%** |
| **Other States / International** | **16%** (Includes MH, MP, GJ, TN, WB, and Nepal) |
* **International Expansion:** Pending regulatory approvals to commence operations in **Bangladesh, Sri Lanka, and Vietnam**.
---
### **Financial Performance & Capital Structure**
The company maintains a conservative capital structure, though recent regulatory shifts have pressured short-term liquidity.
#### **Consolidated Financial Summary**
| Metric (₹ Crore) | FY24 (A) | FY25 (A) | 9MFY26 (UA) |
| :--- | :--- | :--- | :--- |
| **Total Operating Income** | **252.5** | **296.6** | **206.0** |
| **PBILDT** | **44.34** | **45.15** | **23.92** |
| **Profit After Tax (PAT)** | **28.31** | **27.42** | **~16.5 (Est.)** |
| **Overall Gearing (x)** | **0.32** | **0.25** | **N.A.** |
#### **IPO Proceeds Utilization (as of Sept 2025)**
* **NASPL New Plant:** **₹14.20 Cr** (100% utilized)
* **NATL Plant Expansion:** **₹13.09 Cr** (100% utilized)
* **Net Proceeds:** **₹100.95 Cr** (after **₹11.05 Cr** expenses)
---
### **Strategic Growth Pillars**
1. **Product Diversification:** Pursuing technical import licenses for **Emamectin** and **Carbendizum** and expanding the **biostimulant** range.
2. **Agri-Seed Business:** The Board has authorized entry into crop seed production through **Nova Agri Seeds India Private Limited**.
3. **Drone Training Centres:** Establishing specialized centers in **Andhra Pradesh** to promote precision agriculture and create a service-based revenue stream.
4. **Employee Alignment:** Implementation of the **Share Based Employee Benefit Scheme 2022** to retain key talent.
---
### **Risk Factors & Sensitivities**
#### **Regulatory & Market Risks**
* **Biostimulant Disruption:** The **Fertilizer Control Order (FCO)** led to the cancellation of **8,000+** provisional registrations nationwide. As biostimulants contributed **~30%** of NATL's revenue, this caused a **28% decline** in **Q3FY26** income.
* **Geographical Concentration:** **55%** of revenue is derived from **Telangana**, making the company vulnerable to local climatic and political shifts.
* **Seasonality:** High dependence on monsoon patterns and harvest cycles (Rabi/Kharif).
#### **Financial & Liquidity Sensitivities**
* **Stretched Operating Cycle:** The cycle increased to **217 days** in **FY25**. Receivables stood at **₹214 crore** as of Dec 2025, with **55%** outstanding for over six months.
* **Working Capital Pressure:** Average utilization of cash credit facilities reached **~96%** through **January 2026**.
* **Credit Ratings:**
* **CARE Ratings:** **CARE BBB; Negative** (Outlook revised from Positive in Feb 2026 due to biostimulant regulatory gaps).
* **Acuité Ratings:** **ACUITE BBB; Stable**.
#### **Governance & External Factors**
* **Management Turnover:** Resignation of two Whole-Time Directors in **April 2024**.
* **Legal:** A **2024 GST investigation** by APSDRI was settled with a payment of **₹18.31 lakhs** and is now closed.
* **Macro Factors:** Vulnerability to global commodity price volatility and interest rate sensitivity (estimated **₹32.89 lakh** PBT impact per **100 bps** rise).